,54 However, our study distinguishes itself by uniquely combining PLGA-based microspheres with CD34-specific aptamers for the targeted delivery of Toc to CD34+ orbital fibroblasts in TAO. This evidence concerns the gene RHBDF2 and thromboangiitis obliterans.